-
-
7 . Periodical
Prognostic Impact of Germ-Line FCGR2A(H131R), FCGR3A(F158V), and FCGR2B(I232T) Single Nucleotide Polymorphisms in Lymphoma Patients Treated with Obinutuzumab or Rituximab in Combination with Chemotherapy: Results from the Phase III GALLIUM and GOYA Clinical Trials
- 저자
- by Strefford, Jonathan C; Nowicka, Malgorzata; Hargreaves, Chantal; Iriyama, Chisako; Latham, Kate V, et al.
- 소스
- Blood; November 2018, Vol. 132 Issue: 1, Number 1 Supplement 1 p4109-4109, 1p